Julide T Celebi, MD
- PROFESSOR | Pathology
- PROFESSOR | Dermatology
- PROFESSOR | Oncological Sciences
Specialties:Dermatology, Anatomic Pathology
Research Topics:Cancer Genetics, Metastasis, Oncogenes, Tumor Suppressor Genes, Tumorigenesis
Dr. Celebi is a Professor and Vice Chair of the Department of Dermatology and Professor of the Department of Pathology at the Icahn School of Medicine at Mount Sinai. She is a physician of the Mount Sinai Hospital.
She completed her dermatology residency training at Columbia University’s College of Physicians & Surgeons in New York. She joined the faculty at Columbia University in 1998 and completed translational and basic science research training in cancer genetics. Dr. Celebi is a recipient of numerous prestigious awards; the Women’s Dermatologic Society Mentorship Program Award, the Dermatology Foundation’s Clinical Career Development Award, and the Irving Scholarship from Columbia University. In addition, Dr. Celebi is the recipient of the Skin Cancer Foundation’s Frederick E. Mohs Memorial Award, NIH Mentored Clinical Scientist Award, and numerous Foundation and NIH grants for her groundbreaking work on melanoma. Her laboratory studies focus on the molecular genetics of melanoma. She is an active member of the Tisch Cancer Institute located at the Norma and Leon Hess Center for Science and Medicine.
She is a member of the American Academy of Dermatology, Society for Investigative Dermatology, American Association for Cancer Research, Society for Melanoma Research, and New York Dermatologic Society.
Dr. Celebi’s dermatology expertise includes:
1) Moles and Melanoma: skin cancer screening, melanoma risk assessment and surveillance, state-of-the-art imaging systems such as mole mapping, dermoscopy and MelaFind.
2) General Dermatology
3) Cosmetic Dermatology, Skin Health and Appearance: Botox and filler injections, chemical peels and laser surgery.
Dr. Celebi is an exceptional leader, a brilliant and caring physician, a devoted educator, and an insightful scientist. She sees patients at our eastside location.
Appointments can be made by calling (212) 241-9728 or using the online appointment link on this page.
American Board of Dermatology
- Actinic Keratosis
- Basal Cell Carcinoma
- Botox Cosmetic
- Botulinum Injections-Cosmetic
- Botulinum Toxin Injections
- Botulinum Toxin for Hyperhidrosis
- Botulinum Toxin for Wrinkles
- Clear & Brilliant
- Cosmetic Consultation
- Cosmetic Surgery
- Facial Rejuvenation
- General Dermatology
- Laser Resurfacing
- Seborrheic Keratosis
- Skin Biopsy
- Skin Cancer Screening
- Skin Health Appearance Consultation
- Skin Lesion Removal
- Squamous Cell Carcinoma
Multi-Disciplinary Training AreasCancer Biology [CAB], Genetics and Data Science [GDS]
MD, Istanbul University
Internship, Internal Medicine, Shands Hospital, Jacksonville
Residency, Dermatology, Columbia University
Notch Inhibition in Melanoma
Improving Diagnostic Precision of Melanoma Using Genetic Information
The Celebi laboratory studies the following topics; Melanoma, Melanoma Precursors, Moles, Oncogenes, Tumor Suppressor Genes, Genomics, Cancer Genetics, and Cancer Biology.
FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification. Nature Cell Biology 2015 March; 17(3).
FBXW7 mutations in melanloma and a new therapeutic paradigm. Journal of the National Cancer Institute 2014 May; 106(6).